← Evidence map

TrialmSystems2022

Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes.

Baoqing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

65 papers cite itlatest 60 shown

2022
…
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35343796